Stay updated on M7824 and Eribulin in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the M7824 and Eribulin in Metastatic TNBC Clinical Trial page.

Latest updates to the M7824 and Eribulin in Metastatic TNBC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRecruitment is now marked as closed with 'No longer looking for participants'. In addition, navigation and heading labels were updated, including the replacement of 'Intervention / Treatment' with 'Intervention/Treatment', and new sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, along with a revision tag updated to v3.6.0.SummaryDifference0.6%

- Check15 days agoChange DetectedUpdated the page revision from v3.5.4 to v3.5.5, reflecting a newer version of the study record.SummaryDifference0.1%

- Check37 days agoChange DetectedA new page revision, v3.5.4, was added and the previous revision v3.5.3 removed, signaling an update to the page's revision history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page’s revision/version label in the footer was updated from v3.5.2 to v3.5.3, indicating a site release update rather than a change to the clinical trial information.SummaryDifference0.1%

- Check65 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check94 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No content or study data were altered.SummaryDifference0.1%

Stay in the know with updates to M7824 and Eribulin in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 and Eribulin in Metastatic TNBC Clinical Trial page.